NCT00082251View on ClinicalTrials.gov

Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Hypercholesterolemia
Interventions
DRUG

Niacin extended release and simvastatin tablets

Sponsors
All Listed Sponsors
lead

Kos Pharmaceuticals

INDUSTRY

NCT00082251 - Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST | Biotech Hunter | Biotech Hunter